Colivelin TFA is primarily used in neuroscience research due to its neuroprotective properties. It has been shown to protect neurons against apoptosis and degeneration, making it a valuable tool in studies related to neurodegenerative diseases such as Alzheimer's. The compound enhances cell survival by activating key signaling pathways involved in neuronal protection, particularly the STAT3 pathway. It also demonstrates cognitive-enhancing effects in animal models, improving memory and learning, which supports its potential use in developing treatments for cognitive impairments. Due to its ability to cross the blood-brain barrier, Colivelin TFA is especially useful in preclinical studies aiming to evaluate therapeutic strategies for brain-related disorders.